Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-042670
Filing Date
2023-04-06
Accepted
2023-04-06 16:00:31
Documents
19

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A tm232007-2_pre14a.htm   iXBRL PRE 14A 969718
6 GRAPHIC sg_jillcmilne-bw.jpg GRAPHIC 12669
7 GRAPHIC bc_capandtsr-4c.jpg GRAPHIC 127416
8 GRAPHIC bc_capandnetincome-4c.jpg GRAPHIC 147832
9 GRAPHIC px_page01-bw.jpg GRAPHIC 786461
10 GRAPHIC px_page02-bw.jpg GRAPHIC 968413
  Complete submission text file 0001104659-23-042670.txt   6484829

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20221231.xsd EX-101.SCH 7968
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxs-20221231_def.xml EX-101.DEF 5841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20221231_lab.xml EX-101.LAB 13545
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20221231_pre.xml EX-101.PRE 4773
13 EXTRACTED XBRL INSTANCE DOCUMENT tm232007-2_pre14a_htm.xml XML 128510
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37467 | Film No.: 23806121
SIC: 2834 Pharmaceutical Preparations